jonathan
kipni
homepag
http
wwwmedicinevirginia
edubasicsciencedepartmentsneuroscifacultykipni
cell
recogn
peptid
bound
mhc
class
class
ii
molecul
cell
surfac
specif
recognit
confer
clonotyp
cell
receptor
tcr
made
two
separ
chain
manufactur
variabl
v
divers
join
j
constant
c
gene
fragment
process
somat
gene
rearrang
process
involv
nucleotid
insert
delet
v
j
junction
chain
random
v
j
junction
fact
tcr
heterodim
two
separ
rearrang
chain
result
theoret
repertoir
uniqu
tcr
mous
theoret
number
possibl
tcr
human
like
order
magnitud
larger
human
possess
variabl
gene
compar
gene
mice
variabl
compar
must
cell
crossreact
abstract
clonal
select
theori
propos
individu
cell
specif
singl
peptidemhc
antigen
howev
repertoir
cell
receptor
tcr
dwarf
vast
array
potenti
foreign
peptidemhc
complex
comprehens
system
requir
cell
recogn
numer
peptid
thu
crossreact
compromis
specif
profound
implic
chanc
natur
peptidemhc
ligand
optim
fit
cognat
tcr
small
almost
alway
morepot
agonist
furthermor
tcr
rais
specif
peptidemhc
complex
vivo
best
avail
solut
naiv
cell
pool
unlik
best
possibl
solut
substanti
greater
number
tcr
could
theoret
produc
system
view
tcr
recognit
provid
plausibl
caus
autoimmun
diseas
substanti
scope
multipl
therapeut
intervent
divers
tcr
base
six
complementaritydetermin
region
cdr
engag
peptid
mhc
molecul
fig
typic
mhc
class
class
ii
molecul
present
peptid
endogen
exogen
antigen
respect
mhc
class
molecul
closedend
peptidebind
groov
bind
peptid
amino
acid
length
longer
peptid
becom
increasingli
distort
central
region
mhc
class
molecul
peptid
length
increas
result
peptid
bulg
contrast
end
mhc
class
ii
peptidebind
cleft
open
allow
even
longer
peptid
extend
beyond
groov
without
bulg
fig
c
clonal
select
theori
propos
individu
lymphocyt
specif
singl
antigen
recognit
altern
ligand
unlik
mani
year
concept
huge
number
tcr
success
provid
immun
foreign
peptid
oneclonotypeonespecif
paradigm
accept
howev
sever
worker
question
concept
notabl
mason
call
abandon
notion
semin
thesi
topic
see
ref
mani
reason
paradigm
shift
base
simpl
arithmet
effect
immun
requir
recognit
potenti
foreign
peptid
inde
put
context
cell
weigh
kilogram
notion
immun
coverag
naiv
pool
monospecif
tcr
suggest
clonal
select
theori
clearli
absurd
cell
human
recent
studi
estim
distinct
tcr
human
naiv
cell
pool
human
mhc
molecul
encod
within
hla
locu
hla
locu
polymorph
region
human
genom
known
encod
allel
variant
across
popul
larg
number
variant
present
appreci
frequenc
hla
loci
among
fastest
evolv
code
region
human
genom
individu
express
six
differ
classic
peptidepres
hla
class
molecul
two
hlaa
two
hlab
two
hlac
six
hla
class
ii
molecul
two
hladr
two
hladq
two
hladp
express
wide
varieti
hla
molecul
ensur
individu
across
popul
present
differ
antigen
peptid
provid
greatest
chanc
individu
may
surviv
emerg
infect
extrem
difficult
link
hla
divers
past
pandem
evid
import
infecti
diseas
drive
hla
select
seen
current
emerg
infecti
diseas
exampl
homozygos
hla
class
allel
result
faster
diseas
progress
hiv
infect
hla
class
allel
associ
lower
viral
load
protect
diseas
variou
factor
addit
cell
immun
thought
contribut
mainten
hla
divers
includ
natur
killer
cell
recognit
mate
select
transmiss
tumour
overal
fact
mutat
alter
amino
close
end
mhc
class
bind
groov
caus
long
peptid
bulg
bind
groov
bulg
increas
addit
amino
acid
peptid
contrast
end
mhc
class
ii
bind
cleft
open
allow
accommod
much
longer
peptid
without
need
peptid
kink
e
imag
show
hlaa
grey
present
immunodomin
glctlvaml
peptid
stick
model
epsteinbarr
viru
grey
present
peptid
myelin
basic
protein
mbp
tcr
dock
peptidemhc
complex
diagon
mode
conserv
bind
mhc
class
class
ii
molecul
colour
indic
dock
footprint
tcr
tcr
cognat
peptidemhc
complex
show
footprint
mhc
complex
six
cdr
loop
gener
germlineencod
loop
interact
mainli
mhc
molecul
wherea
hypervari
loop
sit
peptid
howev
small
structur
databas
compil
date
alreadi
contain
exampl
make
substanti
interact
peptid
import
role
contact
mhc
molecul
tcr
bind
degeneraci
structur
recognit
tcr
hla
molecul
roughli
conserv
diagon
mode
bind
peptidemhc
complex
suggest
tcr
interact
conform
rule
engag
fig
rule
proffer
form
tcr
interact
codon
interact
mhc
class
ii
molecul
form
restrict
triad
consist
three
larg
conserv
residu
mhc
class
molecul
interact
tcr
rule
fit
gener
observ
arrang
tcrpeptidemhc
interact
germlineencod
nonrearrang
element
tcr
contact
germlin
element
mhc
molecul
wherea
nongermlin
somat
rearrang
loop
contact
random
peptid
element
fig
howev
conveni
rule
fail
match
structur
tcrpeptidemhc
complex
gener
date
mhc
mutat
studi
show
depend
fix
pairwis
interact
tcr
peptidemhc
complex
vari
wide
individu
tcr
peptidemhc
complex
also
chang
confirm
follow
tcr
bind
thu
clear
tcrpeptidemhc
interact
rigidli
conserv
rather
allow
consider
flexibl
within
confin
gener
orient
bind
rule
tumourspecif
tcr
provid
excel
exampl
larg
chang
tcr
orient
increas
cell
crossreact
tcr
engag
nineaminoacid
peptid
aagigiltv
peptid
elagigiltv
overlap
sequenc
context
hlaa
adopt
differ
orient
two
peptidemhc
complex
tcrbind
plastic
extend
beyond
differ
peptid
bind
regist
differ
peptid
bind
angl
peptidemhc
complex
cdr
loop
extrem
flexibl
mous
tcr
structur
solv
complex
b
ref
ref
b
ref
box
extens
cell
crossreact
appar
specif
incongru
proteinogen
amino
acid
possibl
gener
vast
number
peptid
length
present
mhc
molecul
see
tabl
cell
specif
given
cell
recogn
tini
fraction
univers
peptid
present
given
mhc
molecul
multispecif
peptid
univers
larg
way
exampl
cell
recogn
million
peptid
less
million
chanc
recogn
peptid
chosen
random
entir
peptid
univers
number
indic
cell
recogn
million
differ
peptid
test
recognit
random
peptid
rate
everi
minut
averag
would
take
year
crossreact
seen
even
total
number
overlap
peptid
made
entir
human
proteom
extrem
small
fraction
possibl
peptid
exampl
fewer
total
possibl
number
peptid
made
human
proteom
environ
cell
function
import
number
frequenc
function
recognit
unrel
peptid
process
present
mhc
molecul
assum
possibl
peptid
present
mhc
molecul
function
recognit
peptid
singl
tcr
translat
frequenc
crossreact
good
accord
experiment
attempt
directli
measur
paramet
thu
sheer
size
possibl
peptid
univers
allow
cell
enorm
crossreact
appear
specif
within
environ
requir
oper
acid
sequenc
hla
class
class
ii
molecul
cluster
around
peptidebind
cleft
often
alter
peptid
sequenc
preferenti
bound
hla
molecul
strongli
suggest
hla
divers
upheld
increas
varieti
peptid
display
tcr
recogn
peptid
antigen
present
hla
variant
unlik
b
cell
receptor
protein
sequenc
tcr
fix
tcr
never
undergo
affin
matur
thu
tcr
express
naiv
cell
requir
respond
foreign
antigen
despit
never
encount
unabl
adapt
protein
sequenc
level
tcr
repertoir
unabl
recogn
virtual
foreign
peptid
bound
self
mhc
molecul
pathogen
usual
evolv
mani
million
time
faster
vertebr
host
would
expect
rapidli
evolv
exploit
cell
blind
spot
overwhelm
host
difficult
conceiv
obviou
univers
mechan
might
transmit
knowledg
present
epitop
previou
infect
gener
within
tcr
cdr
loop
absenc
prior
knowledg
epitop
might
encount
cell
immun
must
provid
immun
cover
possibl
foreign
peptid
contain
appropri
anchor
bind
self
mhc
molecul
univers
cover
repres
major
challeng
immun
system
possibl
array
peptid
manufactur
proteinogen
amino
acid
length
bind
self
mhc
molecul
vast
box
fact
theoret
number
possibl
peptid
cell
might
provid
immun
even
greater
possibl
rais
specif
cell
respons
peptid
contain
amino
acid
posttransl
modif
glycosyl
citrullin
phosphoryl
cysteinyl
dimer
thu
number
potenti
foreign
peptidemhc
complex
cell
might
encount
dwarf
number
tcr
avail
consid
challeng
dispar
met
compromis
antigen
specif
individu
cell
capabl
respond
enorm
number
differ
peptidemhc
complex
inevit
extens
cell
crossreact
profound
consequ
includ
provid
plausibl
caus
autoimmun
diseas
also
discuss
consequ
tcr
bind
degeneraci
offer
substanti
scope
multipl
therapeut
intervent
recent
describ
tcr
isol
patient
type
diabet
recogn
residu
preproinsulin
molecul
ppi
present
context
hlaa
ref
undergo
structur
rearrang
follow
ligand
bind
still
huge
crossreact
despit
rigid
lock
key
bind
mode
cell
express
tcr
respond
million
peptid
least
strongli
respond
ppi
peptid
peptid
identifi
potent
ppi
activ
tcrexpress
cell
differ
ppi
seven
ten
amino
acid
posit
promiscu
explain
structur
tcrppi
complex
tcr
exhibit
peptidecentr
bind
focus
two
amino
acid
peptid
residuefocus
mode
bind
presum
allow
substitut
posit
case
must
consider
stabil
interact
anoth
exampl
peptidecentr
bind
singl
amino
acid
interchang
within
two
hiv
envelop
epitop
shown
reciproc
swap
specif
two
cell
clone
suggest
domin
focu
singl
amino
acid
residu
peptid
within
peptidemhc
complex
might
reason
common
inde
tcrpeptidemhc
structur
describ
date
show
usual
upwardfac
residu
peptid
contribut
inter
action
tcr
peptidemhc
complex
thu
data
limit
number
tcr
structur
avail
indic
tcr
exhibit
substanti
bind
degeneraci
extrem
flexibl
andor
focus
interact
domin
peptid
residu
fig
togeth
bind
promiscu
tcr
interfac
flexibl
mhcbind
motif
often
allow
accommod
sever
amino
acid
primari
mhc
anchor
posit
enabl
substanti
number
peptid
act
agonist
given
tcr
possibl
gener
vast
number
peptid
length
recogn
cell
proteinogen
amino
acid
even
conserv
estim
predict
substanti
peptid
possess
anchor
allow
bind
singl
mhc
molecul
take
peptid
exampl
possibl
gener
differ
peptid
macrolevel
chang
enabl
cell
receptor
tcr
bind
peptidemhc
complex
alter
peptid
bind
angl
red
dot
line
andor
peptid
bind
regist
black
dot
line
within
roughli
diagon
bind
mode
cartoon
show
footprint
tcr
complementaritydetermin
region
cdr
loop
project
onto
peptidemhc
platform
b
microlevel
cdr
loop
flexibl
enabl
accommod
differ
peptidemhc
landscap
cartoon
show
side
view
tcr
engag
peptidemhc
complex
c
structur
studi
show
tcr
focu
two
four
upwardfac
peptid
residu
exampl
tcr
focus
two
peptid
residu
shown
red
residuefocus
interact
allow
tcr
toler
multipl
amino
acid
substitut
posit
peptid
indic
differ
colour
exampl
mutual
exclus
repres
possibl
mhcbind
motif
often
allow
differ
residu
primari
mhc
anchor
also
note
tcr
chang
conform
peptidemhc
complex
follow
engag
amino
acid
length
amino
acid
assum
least
peptid
bind
given
self
mhc
molecul
heterozyg
human
antigenpres
cell
could
theoret
present
differ
peptid
six
mhc
class
molecul
six
mhc
class
ii
molecul
furthermor
mhc
class
ii
molecul
present
longer
peptid
frameshift
within
openend
bind
groov
fig
mason
calcul
mhc
class
ii
molecul
could
theoret
present
almost
differ
peptid
assum
peptid
associ
mhc
class
ii
molecul
without
even
consid
possibl
posttransl
modif
summari
number
potenti
peptid
antigen
exce
number
tcr
avail
respond
mani
order
magnitud
cell
provid
comprehens
immun
cover
one
capabl
recogn
mani
peptid
theoret
argument
mason
suggest
cell
must
recogn
averag
least
million
individu
peptid
recent
gain
traction
result
data
demonstr
level
crossreact
provid
plausibl
structur
mechan
occurr
cell
audit
thymu
react
weakli
self
peptidemhc
ligand
posit
select
cell
bear
tcr
react
strongli
self
antigen
cull
stage
extens
tcr
bind
degeneraci
crossrecognit
peptidemhc
molecul
thymocyt
elegantli
demonstr
studi
show
remark
comprehens
cell
repertoir
select
singl
peptid
result
cell
activ
peptid
unrel
sequenc
peptid
select
compel
evid
cell
exhibit
extens
crossreact
come
studi
combinatori
peptid
librari
compris
almost
possibl
peptid
particular
length
librari
usual
use
seri
sublibrari
laid
positionalscan
format
sublibrari
amino
acid
fix
posit
posit
made
equimolar
mix
remain
amino
acid
note
cystein
gener
exclud
random
posit
avoid
problem
oxid
see
supplementari
inform
figur
studi
librari
cell
activ
assay
indic
agonist
ligand
contain
sever
differ
amino
acid
mani
posit
sever
studi
gone
use
approach
prove
mason
hypothesi
show
individu
cell
clone
realli
recogn
million
differ
individu
peptid
context
singl
mhc
molecul
antigen
sensit
cell
abil
respond
weaker
tcr
ligand
inexor
link
cell
sensit
antigen
fix
paramet
memori
cell
recogn
concentr
peptid
antigen
lower
recogn
naiv
cell
individu
cell
clone
gener
progeni
high
low
antigen
sensit
antigen
sensit
regul
chang
tcr
express
level
cluster
cell
surfac
chang
express
function
costimulatori
molecul
differenti
control
phosphatas
pathway
dampen
cell
signal
alter
glycosyl
statu
tcr
cellsurfac
molecul
review
ref
although
mechan
may
regul
antigen
sensit
cell
thu
abil
cell
crossrecogn
weak
tcr
ligand
difficult
conceiv
might
use
tune
biophys
tcr
engag
specif
ligand
contrast
glycoprotein
uniqu
role
coreceiv
peptidemhc
molecul
bind
larg
invari
site
mhc
class
ii
mhc
class
molecul
respect
thu
coreceptor
might
possess
abil
differenti
regul
respons
tcr
ligand
therebi
modul
tcr
specif
inde
known
affect
onrat
offrat
tcrpeptidemhc
class
engag
therefor
modul
kinet
tcr
bind
differ
peptidemhc
ligand
demonstr
strength
peptidemhc
class
interact
substanti
effect
cell
crossreact
import
realiz
although
tcr
sequenc
invari
tcr
sensit
agonist
ligand
therefor
cell
crossreact
fix
vari
throughout
develop
number
paramet
idea
immun
cover
provid
limit
number
highli
crossreact
cell
posit
neg
implic
presenc
pool
crossreact
cell
recogn
larg
number
glossari
alter
peptid
ligand
apl
peptid
analogu
deriv
origin
antigen
peptid
commonli
amino
acid
substitut
residu
contact
cell
receptor
tcr
alter
tcr
engag
result
differ
activ
consequ
induc
wildtyp
index
antigen
peptid
measur
sensit
cell
densiti
cognat
antigen
antigenpres
cell
surfac
cell
receptor
tcr
affin
peptidemhc
complex
larg
role
antigen
sensit
paramet
also
affect
express
molecul
influenc
cellcel
contact
downstream
signal
transduct
result
tcrpeptidemhc
engag
theori
proffer
niel
jern
state
alreadi
vast
array
lymphocyt
bodi
infect
challeng
antigen
select
clonal
expand
singl
correspond
lymphocyt
b
cell
cell
preexist
lymphocyt
pool
differ
specif
clonal
lymphocyt
popul
elimin
antigen
cdr
region
within
antigen
receptor
complement
shape
antigen
cdr
variabl
part
antigen
receptor
larg
respons
divers
molecul
cdr
allow
antibodi
cell
receptor
recogn
vast
repertoir
antigen
term
use
describ
immun
respons
pathogen
provid
immun
nonident
pathogen
heterolog
immun
mediat
crossreact
cell
antibodi
resembl
epitop
contain
microbi
host
protein
lead
crossreact
cell
host
footprint
immun
respons
establish
first
exposur
pathogen
specif
memori
cell
popul
preferenti
reexpand
reexpos
antigen
one
similar
therebi
limit
clonal
expans
new
antigenspecif
cell
similar
mechan
propos
b
cell
respons
reaction
cell
one
distinct
peptidemhc
ligand
refer
promiscu
cell
receptor
tcr
engag
allow
singl
tcr
bind
differ
peptidemhc
complex
pathogenderiv
peptid
self
peptid
cell
prime
crossrecognit
autoimmun
attack
tcr
tissu
cell
peptid
respond
self
peptid
peripheri
number
posit
consequ
first
crossreact
cell
repertoir
gener
near
perfect
solut
huge
challeng
provid
effect
immun
cover
allow
limit
number
cell
provid
immun
virtual
foreign
peptid
bind
self
mhc
molecul
second
system
limit
number
huge
crossreact
cell
tempor
spatial
favour
far
fewer
cell
need
scan
infect
cell
clonal
select
theori
rigidli
upheld
third
corollari
extens
cell
crossreact
sever
tcr
like
recogn
one
peptid
thu
cell
respons
polyclon
polyclon
recognit
peptidemhc
molecul
make
substanti
difficult
pathogen
escap
immun
recognit
mutat
escap
recognit
one
tcr
might
recogn
anoth
fourth
extens
cell
crossreact
also
provid
excel
conserv
resourc
gener
one
weapon
sever
trigger
sever
document
exampl
show
individu
cell
clone
target
one
infect
differ
peptid
phenomenon
known
heterolog
immun
heterolog
immun
relat
pathogen
common
well
known
immun
cowpox
provid
cover
smallpox
tuberculosi
vaccin
bacterium
mycobacterium
bovi
bacillu
bcg
provid
protect
leprosi
exist
extens
cell
crossreact
mean
heterolog
immun
extend
beyond
crossrecognit
pathogen
high
sequenc
similar
allow
exampl
bcginduc
cell
also
provid
immun
poxvirus
similarli
cell
specif
human
papillomaviru
ymldlqpet
peptid
also
recogn
tmldiqp
peptid
coronaviru
inde
cellmedi
heterolog
immun
extend
dissimilar
antigen
exampl
cell
specif
immunodomin
gilgfvftl
peptid
influenza
viru
often
recogn
epsteinbarr
viru
epitop
glctlvaml
immuno
domin
hivderiv
slyntvatl
antigen
restrict
extent
heterolog
immun
import
human
immun
yet
fulli
known
potenti
posit
outcom
phenomenon
clear
heterolog
immun
could
also
deleteri
effect
document
neg
consequ
heterolog
immun
includ
influenzaspecif
cell
contribut
lymphoprolifer
epsteinbarr
virusassoci
mononucleosi
crossrecogn
peptid
deriv
hepat
c
viru
hcv
increas
sever
hcvassoci
liver
patholog
also
possibl
heterolog
immun
via
cell
crossreact
could
encourag
suboptim
respons
second
pathogen
owe
origin
antigen
sin
antigen
sin
could
extend
beyond
simpl
case
suboptim
sensit
second
antigen
situat
origin
antigen
establish
helper
h
h
h
respons
bia
inappropri
second
pathogen
howev
obviou
detriment
consequ
cell
crossreact
vast
number
individu
peptid
potenti
system
caus
autoimmun
fig
although
strongli
selfreact
cell
delet
thymu
weakli
crossreact
cell
may
surviv
becom
activ
peripheri
crossrecognit
peptid
infecti
agent
phenomenon
known
molecular
mimicri
memori
cell
stimul
peptid
concentr
lower
requir
stimul
naiv
cell
therefor
like
memori
cell
could
stimul
crossreact
peptid
affin
tcr
far
lower
origin
pathogenderiv
peptid
situat
pathogenmedi
prime
would
obligatori
function
crossrecognit
self
peptid
notion
consist
observ
infect
precipit
autoimmun
diseas
compromis
impos
cell
huge
crossreact
order
provid
complet
immun
cover
dictat
individu
tcrpeptidemhc
pair
highli
like
suboptim
thu
possibl
improv
bind
given
tcr
cognat
antigen
enhanc
specif
molecular
match
inde
yeast
display
phage
display
comput
design
use
produc
tcr
bind
peptidemhc
complex
extrem
high
affin
k
pm
halfliv
mani
hour
mhc
class
pathway
predict
present
least
one
peptid
cell
surfac
everi
intern
produc
protein
allow
tcr
potenti
target
cell
base
express
protein
fig
consequ
tcr
might
consider
advantag
regular
antibodybas
therapi
target
substanti
greater
number
cellular
protein
furthermor
substanti
evid
possibl
improv
affin
almost
peptid
antigen
given
natur
tcr
thu
ampl
scope
ration
design
therapeut
intervent
exploit
fact
natur
tcrpeptidemhc
interact
improv
upon
enhanc
tcr
tcr
gene
transfer
therapi
rigour
thymic
select
ensur
natur
tcr
bind
ubiquit
self
tumourassoci
antigen
substanti
lower
affin
bind
pathogenderiv
antigen
natur
tcrpeptidemhc
interact
affin
measur
term
k
within
rang
tcr
bind
affin
affin
halflif
correl
antigen
sensit
place
natur
antitumour
cell
distinct
disadvantag
compar
pathogenreact
counterpart
transfer
tcr
gene
recipi
host
cell
follow
adopt
transfer
cell
patient
allow
passiv
transfer
immun
provid
use
mechan
break
toler
tumour
antigen
strategi
alreadi
shown
promis
patient
malign
melanoma
room
improv
transfer
gene
encod
tcr
affin
matur
bind
tumourassoci
peptidemhc
complex
affin
high
best
antivir
cell
k
nm
enhanc
tcr
solubl
therapi
highaffin
solubl
tcr
provid
effici
mean
cellular
target
intracellular
antigen
present
mhc
molecul
vivo
fig
solubl
tcr
link
molecul
antibodi
fab
fragment
deliv
molecul
site
antigen
express
vivo
despit
low
copi
number
peptidemhc
molecul
copi
per
cell
recent
use
solubl
tcr
fuse
fab
fragment
induc
tumour
regress
vivo
bispecif
cellengag
tcr
function
recruit
polyclon
cell
via
fab
compon
crosslink
tcr
induc
cell
activ
molecul
bound
target
cell
surfac
becom
potent
activ
antigenexperienc
cell
promot
lysi
target
express
ten
cognat
peptidemhc
complex
fig
similar
approach
could
use
dampen
autoimmun
crosslink
inhibitori
receptor
cytotox
lymphocyt
antigen
fact
tcr
capabl
recogn
enorm
number
ligand
pave
way
therapi
base
alter
peptid
ligand
apl
apl
advantag
natur
ligand
bind
strongli
tcr
break
toler
self
ligand
includ
tumourderiv
ligand
previou
assumpt
apl
suggest
alter
buri
anchor
residu
substanti
alter
tcr
bind
prove
incorrect
nevertheless
combinatori
screen
peptid
nonpeptid
ligand
use
determin
prefer
bind
landscap
tcr
circumv
requir
assumpt
natur
system
make
highli
like
tcr
differ
prefer
bind
landscap
enabl
rel
precis
target
specif
tcr
within
popul
antigenspecif
cell
process
term
tcroptim
peptid
skew
repertoir
cell
topsort
use
sort
effect
clonotyp
fig
widespread
applic
figur
enhanc
tcr
solubl
therapi
mhc
class
present
pathway
present
peptid
cell
surfac
intracellular
protein
potenti
allow
solubl
highaffin
monoclon
cell
receptor
tcr
target
cell
base
express
protein
monoclon
tcr
abl
use
mhc
class
present
pathway
see
insid
cell
scan
intern
anomali
xray
vision
open
access
far
greater
rang
diseaserelev
antigen
avail
monoclon
antibodi
tcr
engin
deliv
varieti
molecul
stimul
suppress
immun
system
potenti
payload
includ
antibodi
fab
fragment
deliv
signal
immun
cell
mhcbound
peptid
often
present
low
copi
number
copi
per
cell
payload
deliv
tcr
must
act
low
concentr
b
highaffin
tumourspecif
tcr
manufactur
bispecif
cellengag
molecul
link
fab
fragment
direct
lysi
tumour
cell
cell
therebi
induc
regress
establish
tumour
molecul
activ
cell
monom
concentr
use
cellengag
tcr
bind
cognat
antigen
tumour
cell
surfac
long
halfliv
present
link
fab
fragment
fab
fragment
crosslink
tcr
surfac
antigenexperienc
cell
result
cellular
activ
elimin
target
cell
deliveri
toxin
solubl
tcr
recommend
solubl
tcr
construct
taken
scaveng
cell
macrophag
thu
molecul
deliv
particular
signal
specif
effector
cell
prefer
exampl
highaffin
tcr
could
use
downregul
immun
respons
signal
inhibitori
receptor
cytotox
lymphocyt
antigen
shown
approach
depend
effect
clonotyp
public
occur
individu
restrict
hla
molecul
public
motif
share
individu
relev
hla
molecul
preliminari
studi
use
ex
vivo
peripher
blood
mononuclear
cell
show
approach
use
skew
clonotyp
respond
tumour
antigen
j
ekeruchemakind
et
al
unpublish
observ
similar
approach
could
use
skew
clonotyp
induc
vaccin
hiv
toward
known
difficult
hiv
escap
accumul
evid
includ
direct
estim
total
number
tcr
human
support
mason
notion
abandon
oneclonotypeonespecif
paradigm
suggest
clonal
select
theori
favour
oneclonotypemillionsofspecif
realiti
simpl
arithmet
cell
immun
allow
cell
highli
crossreact
appear
exquisit
specif
environ
expect
function
howev
realiti
cell
immun
dictat
tcr
rare
optim
fit
real
antigen
real
mhcpresent
peptid
antigen
rare
optim
agonist
given
tcr
compromis
provid
multipl
opportun
ration
therapeut
intervent
base
direct
manipul
cell
immun
clonotyp
cell
receptor
tcr
recogn
antigen
equal
one
tcr
may
provid
effect
immun
case
hiv
exampl
one
tcr
may
difficult
viru
escap
tcr
requir
tcr
public
occur
individu
restrict
hla
molecul
publictyp
motif
tcroptim
peptid
clonotyp
could
use
skew
respons
toward
effect
clonotyp
known
rule
enabl
predict
tcr
particular
ligand
stimul
thu
process
requir
pretest
use
vitro
prime
assay
ensur
induc
requir
clonotyp
minim
induct
suboptim
clonotyp
